12 Recruiting Ovarian Cancer Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for ovarian cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Ovarian Cancer studiesPhase 1 / Phase 2 Studies for Ovarian Cancer
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
📍 Research Site — Boston, Massachusetts
View Study & Checklist ➔A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.
📍 University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
📍 Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center — Cleveland, Ohio
View Study & Checklist ➔Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
📍 Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology — New York, New York
View Study & Checklist ➔Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer
📍 Start Cal — Los Angeles, California
View Study & Checklist ➔Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
📍 Research Site — Duarte, California
View Study & Checklist ➔Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
📍 Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California
View Study & Checklist ➔A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer
📍 Georgia Cancer Center at Augusta University — Augusta, Georgia
View Study & Checklist ➔FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
📍 The University of Alabama — Birmingham, Alabama
View Study & Checklist ➔Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
📍 Johns Hopkins Medicine SKCCC — Baltimore, Maryland
View Study & Checklist ➔